Dimensional Fund Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Dimensional Fund Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$191K	Sell	23,227 -1,800	-7%	-$13.8K	﹤0.01%	3248
2022 Q2	$164K	Hold	25,027	–	–	﹤0.01%	3273
2022 Q1	$140K	Buy	25,027 +200	+0.8%	+$824	﹤0.01%	3357
2021 Q4	$116K	Buy	24,827 +1,144	+5%	+$7.1K	﹤0.01%	3418
2021 Q3	$146K	Sell	23,683 -4,662	-16%	-$27.9K	﹤0.01%	3388
2021 Q2	$187K	Hold	28,345	–	–	﹤0.01%	3348
2021 Q1	$207K	Buy	28,345 +3,984	+16%	+$34.4K	﹤0.01%	3285
2020 Q4	$141K	Buy	+24,361	New	+$139K	﹤0.01%	3259
2014 Q4	–	Sell	-28,535	Closed	-$317K	–	3531
2014 Q3	$317K	Sell	28,535 -1,964	-6%	-$25K	﹤0.01%	3217
2014 Q2	$558K	Sell	30,499 -1,269	-4%	-$16.5K	﹤0.01%	3167
2014 Q1	$475K	Sell	31,768 -7,196	-18%	-$129K	﹤0.01%	3205
2013 Q4	$717K	Sell	38,964 -1,658	-4%	-$33.2K	﹤0.01%	3099
2013 Q3	$841K	Buy	40,622 +9,134	+29%	+$209K	﹤0.01%	3073
2013 Q2	$787K	Buy	+31,488	New	+$1.35M	﹤0.01%	3072

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Dimensional Fund Advisors's AVEO Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its AVEO Pharmaceuticals, Inc. (AVEO) stake by 7.2% in Q3 2022, selling an estimated $13.8K and leaving 23,227 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #3248.

Dimensional Fund Advisors first reported a position in AVEO in Q2 2013 and has held it in 14 quarters since. The position peaked at $841K in Q3 2013. 77 funds tracked by Wall St. Rank hold AVEO as of Q3 2022.

Dimensional Fund Advisors held 23,227 shares of AVEO Pharmaceuticals, Inc. worth $191K as of Q3 2022.
Dimensional Fund Advisors sold 1,800 AVEO Pharmaceuticals, Inc. shares in Q3 2022, an estimated $13.8K.
AVEO Pharmaceuticals, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3248 holding.
Dimensional Fund Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 14 quarters since.
Dimensional Fund Advisors's AVEO Pharmaceuticals, Inc. position peaked at $841K in Q3 2013.
77 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.